API
Aceclofenac
KDMF APIs
Aceclofenac
Korean name | 아세클로페낙 |
|---|---|
Category | Central nervous system |
CAS No. | 89796-99-6 |
KDMF registration No. | 20120905-31-C-301-18(6) |
Manufacturer | Jiangxi Synergy Pharmaceutical Co., Ltd |
Specification | EP |
Product information
IUPAC Name | 2-[(2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetyl)oxy]acetic acid |
|---|---|
Synonyms | 2-[(2,6-dichlorophenyl)amino]benzeneacetic acid carboxymethyl ester 2-[(2,6-dichlorophenyl)amino]phenylacetoxyacetic acid 2-[(2',6'-dichlorophenyl)amino]phenylacetoxyacetic acid glycolic acid [o-(2,6-dichloroanilino)phenyl]acetate ester |
Description | Aceclofenac is an oral non-steroidal anti-inflammatory drug (NSAID) with marked anti-inflammatory and analgesic properties used to treat osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. It is reported to have a higher anti-inflammatory action or at least comparable effects than conventional NSAIDs in double-blind studies. Aceclofenac potently inhibits the cyclo-oxygenase enzyme (COX) that is involved in the synthesis of prostaglandins, which are inflammatory mediators that cause pain, swelling, inflammation, and fever. Aceclofenac belongs to BCS Class II as it possesses poor aqueous solubility. It displays high permeability to penetrate into synovial joints where in patients with osteoarthritis and related conditions, the loss of articular cartilage in the area causes joint pain, tenderness, stiffness, crepitus, and local inflammation. Aceclofenac is also reported to be effective in other painful conditions such as dental and gynaecological conditions. In 1991, aceclofenac was developed as an analog of a commonly prescribed NSAID, Diclofenac, via chemical modification in effort to improve the gastrointestinal tolerability of the drug. It is a more commonly prescribed drug in Europe. |
Certificate of Analysis | If you need more information, please contact us. |
If you need additional documents such as specifications or certificates of analysis, please request them together with your inquiry. Our team will review and reply. (02-579-1056 · ace@acebiopharm.com)